Kidney transplantation is the optimal treatment for end-stage renal diseases. Although great
improvement has been achieved, immune tolerance is still the Holy Grail that every organ …

These guidelines cover the care of patients from the period following kidney transplantation
until the transplant is no longer working or the patient dies. During the early phase …

Advances in maintenance immunosuppression over the past three decades have improved
solid organ transplantation outcomes dramatically. Uninterrupted access to …

The success of solid-organ transplantation was made possible by recognizing that
destruction of the graft is caused by an alloimmune-mediated process. For the past decade …

Background The efficacy and safety of minimisation of immunosuppression including early
steroid withdrawal in kidney transplant recipients treated with Basiliximab induction remains …

Background This study compared long-term outcomes of renal transplantation from donors
following donation after circulatory death (DCD) with those following donation after brain …

Background Alemtuzumab induction therapy in kidney transplant patients results in T cell
depletion followed by slow immune reconstitution of memory T cells with reduced immune …

Kidney transplantation has evolved over the years from transplants between identically
matched donors and recipients to successfully transplanting allografts across virtually any …

Background The purpose of this study was to determine the incidence and management
strategies for post-transplant leukopenia/neutropenia in kidney recipients receiving …

This study was conducted to review the outcomes of patients who had undergone surgical
repair of a ureteric stricture following renal transplantation. All patients who developed a …